Prostate Cancer Market Research Report – Forecast to 2023 Global Industry Survey, Growth, Competitive Landscape and Forecasts to 2023
CREATED BY Market Research Future (Part of Wantstats Research & Media Pvt. Ltd.)
Prostate Cancer Market Research Report – Forecast to 2023 Prostate Cancer Market to Achieve Share worth USD 215 Billion By 2023
The global prostate cancer market is showing the steady growth; mainly owing to increase in patient population. According to report published by Centers for Disease Control and Prevention, in 2014, there were around 172,258 men in the United States, who diagnosed with prostate cancer and around 28,343 men died from prostate cancer. These rising number of prostate cancer create an opportunity for the player to introduce innovative treatment option.
Companies are continuously invent new treatment to capture the global market. Thus players invest more in research and development activities. In this regards, Bayer Pharma AG announced that they have many drugs for the treatment of prostate cancer in there pipeline such as Radium-223 dichloride and BAY 1841788 (ODM-201, AR antagonist). Browse Report Details @ https://www.marketresearchfuture.com/reports/prostate-cancer-market-1580
2
www.marketresearchfuture.com
Prostate Cancer Market Research Report – Forecast to 2023 Segmentation:
Global Prostate cancer market has been segmented on the basis of product type; market is segmented into targeted therapies, therapeutic vaccines, hormone therapy and others. On the basis of end users; market is segmented into hospitals, clinics and others.
Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/1580
3
www.marketresearchfuture.com
Prostate Cancer Market Research Report – Forecast to 2023 Application & Major Players in this Research:
Market Prominent Players: Some of the key players in this market are: OncoGenex Pharmaceuticals Inc. (US), Bayer Pharma AG (Berlin), Progenics Pharmaceuticals, Inc. (US), TOLMAR Inc. (US), OncBioMune Pharmaceuticals Inc. (US), Endo Pharmaceuticals Inc., Tokai Pharmaceuticals, Inc. and others.
Commenting on the report, an analyst from Market Research Future (MRFR)’s team said: The competitive market is witnessing several strategies such as mergers and collaborations that could take the market forward. For instance, Illumina bought Edico Genome, a data analysis company that provides solutions for NGS. Myriad Genetics acquired Counsyl, a specialist in carrier screening and non-invasive prenatal screening.
Get Discount @ https://www.marketresearchfuture.com/check-discount/1580
4
www.marketresearchfuture.com
Prostate Cancer Market Research Report – Forecast to 2023 About Us: Market Research Future At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), ContinuousFeed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. For more information kindly visit www.marketresearchfuture.com or contact us at info@marketresearchfuture.com Copyright Š 2018 Market Research Future All Rights Reserved. This document contains highly confidential information and is the sole property of Market Research Future. No part of it may be circulated, copied, quoted, or otherwise reproduced without the written approval of Market Research Future.
5
www.marketresearchfuture.com
THANK YOU
MARKET RESEARCH FUTURE
salesteam@marketresearchfuture.com Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
6
www.marketresearchfuture.com